Share on StockTwits

Ocera Therapeutics (NASDAQ:OCRX) issued its quarterly earnings data on Monday. The company reported ($0.46) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.45) by $0.01, Analyst Ratings News reports.

Ocera Therapeutics (NASDAQ:OCRX) traded down 1.03% on Monday, hitting $5.775. The stock had a trading volume of 23,864 shares. Ocera Therapeutics has a 52 week low of $5.26 and a 52 week high of $19.94. The stock’s 50-day moving average is $6.32 and its 200-day moving average is $9.69. The company’s market cap is $89.7 million.

On the ratings front, analysts at JMP Securities initiated coverage on shares of Ocera Therapeutics in a research note on Wednesday, June 11th. They set an “outperform” rating and a $15.00 price target on the stock.

Ocera Therapeutics, Inc, formerly Tranzyme, Inc, is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing mechanism-based therapeutics for the treatment of upper gastrointestinal (NASDAQ:OCRX) motility disorders.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.